Oaktree Acquisition Corp. III Life Sciences extends its deadline to complete a business combination to November 25, 2026, impacting its strategic direction.
| Name | Oaktree Acquisition Corp. III Life Sciences |
|---|---|
| CIK | 0002029769 |
| Tickers | OACC, OACCU, OACCW |
| Exchanges | Nasdaq, Nasdaq, Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 6770 Blank Checks |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | E9 Cayman Islands |
| Phone | 213-830-6300 |
| Website | — |
| Investor website | — |
| Owner org | 05 Real Estate & Construction |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Oaktree Acquisition Corp. III Life Sciences extends its deadline to complete a business combination to November 25, 2026, impacting its strategic direction.
Oaktree Acquisition Corp. III Life Sciences has postponed its general meeting to October 23, 2026, to allow for further proxy solicitation.
Oaktree Acquisition Corp. III Life Sciences reveals over 13 million shares tendered for redemption as it prepares for a key shareholder vote.
69 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001950677-26-000036 | 005-94673 | 261560228 | 34 | 8426 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001688382-26-000047 | 005-94673 | 261559650 | 34 | 10929 | |||
| 2026-11-13 | 10-Q | 10-Q | 0001193125-26-460799 | 001-42383 | 261553246 | 34 | 4285523 | 1 | 1 | |
| 2026-10-26 | 8-K | 8-K | 3.02,5.03,5.07,9.01 | 0001193125-26-430980 | 001-42383 | 261483385 | 34 | 224872 | 1 | 1 |
| 2026-10-23 | 4 | 4 | 0001193125-26-430503 | 15684 | ||||||
| 2026-10-16 | DEFA14A | DEFA14A | 0001193125-26-423331 | 001-42383 | 261464275 | 34 | 23533 | |||
| 2026-10-16 | 8-K | 8-K | 7.01 | 0001193125-26-423329 | 001-42383 | 261464270 | 34 | 195435 | 1 | 1 |
| 2026-10-15 | DEFA14A | DEFA14A | 0001193125-26-422266 | 001-42383 | 261461327 | 34 | 23133 | |||
| 2026-10-15 | 8-K | 8-K | 7.01 | 0001193125-26-422263 | 001-42383 | 261461324 | 34 | 194780 | 1 | 1 |
| 2026-10-02 | DEF 14A | DEF 14A | 0001193125-26-412601 | 001-42383 | 261437883 | 34 | 406784 | |||
| 2026-09-21 | PRE 14A | PRE 14A | 0001193125-26-396720 | 001-42383 | 261394302 | 34 | 396533 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001950677-26-000024 | 005-94673 | 261283622 | 34 | 8355 | |||
| 2026-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000312069-26-000209 | 005-94673 | 261275421 | 34 | 6171 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-346973 | 001-42383 | 261268008 | 34 | 4039673 | 1 | 1 | |
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001688382-26-000017 | 005-94673 | 26985688 | 34 | 77905 | |||
| 2026-05-13 | 10-Q | 10-Q | 0001193125-26-221814 | 001-42383 | 26974175 | 34 | 3731715 | 1 | 1 | |
| 2026-05-11 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000886982-26-000205 | 005-94673 | 26962584 | 34 | 18219 | |||
| 2026-03-26 | 10-K | 10-K | 0001193125-26-126536 | 001-42383 | 26799143 | 34 | 5058116 | 1 | 1 | |
| 2026-02-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000312069-26-000052 | 005-94673 | 26620745 | 34 | 6151 | |||
| 2025-11-13 | 10-Q | 10-Q | 0001193125-25-280296 | 001-42383 | 251479175 | 34 | 3974165 | 1 | 1 | |
| 2025-10-29 | 3 | 3 | 0001193125-25-256847 | 13923 | ||||||
| 2025-10-29 | 8-K | 8-K | 5.02 | 0001193125-25-256604 | 001-42383 | 251430797 | 34 | 191299 | 1 | 1 |
| 2025-10-22 | 3 | 3 | 0001193125-25-246855 | 13793 | ||||||
| 2025-10-17 | 8-K | 8-K | 5.02 | 0001193125-25-242643 | 001-42383 | 251401587 | 34 | 192300 | 1 | 1 |
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000769993-25-000426 | 005-94673 | 251205432 | 34 | 17193 | |||
| 2025-08-12 | 10-Q | 10-Q | 0001193125-25-178570 | 001-42383 | 251204616 | 34 | 3593208 | 1 | 1 | |
| 2025-07-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-068094 | 005-94673 | 251124902 | 34 | 15425 | |||
| 2025-06-16 | 3 | 3 | 0000950170-25-086786 | 15098 | ||||||
| 2025-06-06 | 8-K | 8-K | 5.02 | 0001193125-25-137105 | 001-42383 | 251031158 | 34 | 191756 | 1 | 1 |
| 2025-05-14 | 10-Q | 10-Q | 0001193125-25-119885 | 001-42383 | 25946293 | 34 | 3276861 | 1 | 1 | |
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-071410 | 005-94673 | 25945695 | 34 | 8359 | |||
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001085146-25-003132 | 005-94673 | 25944012 | 34 | 10221 | |||
| 2025-05-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000312069-25-000398 | 005-94673 | 25941299 | 34 | 6050 | |||
| 2025-05-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000769993-25-000246 | 005-94673 | 25929256 | 34 | 16547 | |||
| 2025-03-27 | 10-K | 10-K | 0001193125-25-065546 | 001-42383 | 25779865 | 34 | 1401263 | |||
| 2025-02-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-021134 | 005-94673 | 25628029 | 34 | 8275 | |||
| 2025-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-019260 | 005-94673 | 25616862 | 34 | 36108 | |||
| 2025-01-07 | 8-K | 8-K | 5.02 | 0001193125-25-002863 | 001-42383 | 25515226 | 34 | 20284 | ||
| 2024-12-11 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-274894 | 001-42383 | 241540246 | 34 | 31089 | ||
| 2024-11-07 | SC 13G | AQR CAPITAL MANAGEMENT LLC | 0001085146-24-005427 | 005-94673 | 241435231 | 34 | 45359 | |||
| 2024-11-05 | 8-K | 8-K | 3.02,8.01,9.01 | 0001193125-24-251274 | 001-42383 | 241427952 | 34 | 100707 | ||
| 2024-10-31 | 4 | 4 | 0000950170-24-119552 | 61899 | ||||||
| 2024-10-31 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-248669 | 001-42383 | 241415291 | 34 | 145209 | ||
| 2024-10-30 | SC 13G | OACC_SC13G.htm | 0001273087-24-000110 | 005-94673 | 241410998 | 34 | 82127 | |||
| 2024-10-25 | 8-K | 8-K | 1.01,3.02,5.03,8.01,9.01 | 0001193125-24-244185 | 001-42383 | 241397574 | 34 | 1234763 | ||
| 2024-10-24 | 424B4 | 424B4 | 0001193125-24-242948 | 333-282508 | 241393324 | 33 | 1885097 | |||
| 2024-10-24 | CERT | 8A_Cert_OACC.pdf | 0001354457-24-000827 | 001-42383 | 241390806 | 34 | 761575 | |||
| 2024-10-23 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-10-23 16:30:00 | 9999999995-24-003251 | 333-282508 | 241390447 | 33 | 1789 | ||
| 2024-10-23 | 3 | 3 | 0000950170-24-116810 | 63092 | ||||||
| 2024-10-23 | 3 | 3 | 0000950170-24-116805 | 18977 | ||||||
| 2024-10-23 | 3 | 3 | 0000950170-24-116802 | 18471 | ||||||
| 2024-10-23 | 3 | 3 | 0000950170-24-116799 | 18312 | ||||||
| 2024-10-23 | 3 | 3 | 0000950170-24-116798 | 18511 | ||||||
| 2024-10-23 | 3 | 3 | 0000950170-24-116797 | 18797 | ||||||
| 2024-10-23 | 3 | 3 | 0000950170-24-116796 | 18416 | ||||||
| 2024-10-23 | 3 | 3 | 0000950170-24-116790 | 18367 | ||||||
| 2024-10-23 | 8-A12B | 8-A12B | 0001193125-24-241503 | 001-42383 | 241387951 | 34 | 16724 | |||
| 2024-10-21 | CORRESP | filename1.htm | 0001193125-24-240542 | 8681 | ||||||
| 2024-10-21 | CORRESP | filename1.htm | 0001193125-24-240541 | 13968 | ||||||
| 2024-10-18 | CORRESP | filename1.htm | 0001193125-24-239703 | 12376 | ||||||
| 2024-10-18 | S-1/A | S-1/A | 0001193125-24-239699 | 333-282508 | 241381353 | 33 | 1955442 | |||
| 2024-10-18 | UPLOAD | filename1.pdf | 0000000000-24-011712 | 377-07367 | 44465 | |||||
| 2024-10-04 | CORRESP | filename1.htm | 0001193125-24-233107 | 17912 | ||||||
| 2024-10-04 | S-1 | S-1 | 0001193125-24-233080 | 333-282508 | 241355201 | 33 | 3569739 | |||
| 2024-10-01 | UPLOAD | filename1.pdf | 0000000000-24-011118 | 377-07367 | 47438 | |||||
| 2024-09-13 | DRSLTR | filename1.htm | 0000950123-24-009225 | 33306 | ||||||
| 2024-09-13 | DRS/A | filename1.htm | 0000950123-24-009224 | 377-07367 | 241298520 | 33 | 3405637 | |||
| 2024-09-05 | UPLOAD | filename1.pdf | 0000000000-24-010081 | 377-07367 | 56058 | |||||
| 2024-08-07 | DRS | filename1.htm | 0000950123-24-007251 | 377-07367 | 241180935 | 33 | 1919612 |
One latest value per concept from companyfacts (55 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityPublicFloat | Entity Public Float | USD | 200.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 2.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 11.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 215,029 | 2024-06-28 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 |
| us-gaap | Assets | Assets | USD | 208.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | AssetsHeldInTrustNoncurrent | Assets Held-in-trust, Noncurrent | USD | 206.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | Cash | Cash | USD | 1.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 1.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 1.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -209,362 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 11.5 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 3.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 6.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | ExpenseRelatedToDistributionOrServicingAndUnderwritingFees | Expense Related to Distribution or Servicing and Underwriting Fees | USD | 3.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions | Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | USD | 4.25M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0001193125-25-178570 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -89,984 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-12 | 0001193125-25-178570 |
| us-gaap | IncreaseDecreaseInDueToRelatedParties | Increase (Decrease) in Due to Related Parties | USD | 225,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | 2.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | -92,025 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | IncreaseDecreaseInPrepaidInsurance | Increase (Decrease) in Prepaid Insurance | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 5.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | Liabilities | Liabilities | USD | 10.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 208.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 3.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 250,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -459,362 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 2.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 5.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 11,824 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 3.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -3.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | PaymentsToAcquireOtherInvestments | Payments to Acquire Other Investments | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 1.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 21,250 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 | |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -9.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 550,000 | 2024-06-28 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -9.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 | |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 25,000 | 2024-06-28 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2024-06-28 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001193125-26-126536 |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | 1.68M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 206.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001193125-26-460799 |